Abstract
Introduction
Single-fraction stereotactic radiosurgery (SRS) is delivered predominantly via two modalities: Gamma Knife, and linear accelerator (LINAC). Implementation of the American Tax Payer Relief Act (ATRA) in 2013 represented the first time limitations specifically targeting SRS reimbursement were introduced into federal law. The subsequent impact of the ATRA on SRS utilization in the United States (US) has yet to be examined.
Methods
The National Cancer Database from 2010–2016 identified brain metastases patients from non-small cell lung cancer throughout the US having undergone SRS. Utilization between GKRS and LINAC was assessed before (2010–2012), during (2013–2014) and after (2015–2016) ATRA implementation.
Results
In 2013, there was a substantial decrease of LINAC SRS in favor of GKRS in non-academic centers. Over the 3-year span immediately preceding ATRA implementation, 39% of all eligible SRS cases received LINAC. There was a modest decrease in LINAC utilization over the 2 years immediately following ATRA implementation (35%), followed by an increase over the next two years (40%). SRS modality showed differences over the three time periods (unadjusted, p = 0.043), primarily in non-academic centers (unadjusted, p = 0.003).
Conclusions
ATRA implementation in 2013 caused an initial spike in Gamma Knife SRS utilization, followed by a decline to rates similar to the years before implementation. These findings indicate that the ATRA provision mandating Medicare reduction of outpatient payment rates for Gamma Knife to be equivalent with those of LINAC SRS had a significant short-term impact on the radiosurgical treatment of metastatic brain disease throughout the US, serving as a reminder of the importance/impact of public policy on treatment modality utilization by physicians and hospitals.
Similar content being viewed by others
References
Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316(4):401–409
Caruso JP, Moosa S, Fezeu F, Ramesh A, Sheehan JP (2015) A cost comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology. J Clin Neurosci 22:184–188
Andrews DW, Bednarz G, Evans JJ, Downes B (2006) A review of 3 current radiosurgery systems. Surg Neurol 66(6):559–564
Government Publishing Office. American Taxpayer Relief Act of (2012). https://www.gpo.gov/fdsys/pkg/BILLS-112hr8enr/pdf/BILLS-112hr8enr.pdf. Accessed 11 Jan 2019
Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872
American College of Surgeons Commission on Cancer (2011) National Cancer Data Base, 2008 Data Submission. American College of Surgeons, Chicago, IL
Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB (2016) Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. J Neurosurg 124(4):1018–1024
McClelland S 3rd, Watson GA (2019) Impact of MRI timing on accuracy of stereotactic radiosurgical planning: visualizing the forest from the trees. Int J Radiat Oncol Biol Phys 103(4):1012–1013
McDonald D, Schuler J, Takacs I, Peng J, Jenrette J, Vanek K (2014) Comparison of radiation dose spillage from the Gamma Knife perfexion with that from volumetric modulated arc radiosurgery during treatment of multiple brain metastases in a single fraction. J Neurosurg 121(Suppl):51–59
McClelland S 3rd, Kim E, Passias PG, Murphy JD, Attia A, Jaboin JJ (2017) Spinal stereotactic body radiotherapy in the United States: a decade-long nationwide analysis of patient demographics, practice patterns, and trends over time. J Clin Neurosci 46:109–112
Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY (2009) Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol 27:4177–4181
Clemens J, Gottlieb JD (2017) In the shadow of a giant: medicare's influence on private physician payments. J Polit Econ 125(1):1–39
Funding
This manuscript received no funding.
Author information
Authors and Affiliations
Contributions
Conception and design: SM; Data collection: CD, YC, JJJ; Statistical analysis: CD, YC; Data analysis and interpretation: CD, YC, SM, GAW, JJJ; Manuscript writing: SM; Final approval of manuscript: SM, CD, YC, GAW, JJJ.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
McClelland, S., Degnin, C., Chen, Y. et al. Impact of the American Tax Payer Relief Act on stereotactic radiosurgery utilization in the United States. J Neurooncol 145, 159–165 (2019). https://doi.org/10.1007/s11060-019-03283-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-019-03283-z